HIV vaccine (GlaxoSmithKline)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHIV vaccine (GlaxoSmithKline)
Drug Alias NameHIV疫苗 - 葛兰素史克艾滋病疫苗 - 葛兰素史克GSK-732462GSK-732461SB-732461 +[6] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesGermany +[5] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAcquired Immunodeficiency SyndromeHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A